Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness — United States and Puerto Rico, April 2020–March 2021

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Munoz-Jordan, Jorge ; Cardona, Jaime ; Beltrán, Manuela ; Colón, Candimar ; Schiffer, Jarad ; Stewart-Clark, Evelene ; Zellner, Briana ; Semenova, Vera ; Li, Yikun ; Jia, Lily Tao ; Maniatis, Panagiotis ; Pawloski, Lucia ; Adams, Laura ; Paz-Bailey, Gabriela ; Rivera-Amill, Vanessa ; Medina, Freddy
• Description:
  The Diagnosis of dengue disease, caused by the dengue Virus (DENV) (a flaviVirus), often requires serologic tTesting during acute and early convalescent phases of the disease. Some symptoms of DENV infection, such as nonspecific fever, are similar to those caused by infection with SARS-CoV-2, the Virus that causes COVID-19. In studies with few COVID-19 cases, positive DENV immunoglobulin M (IgM) results were reported with various serologic tests, indicating possible cross-reactivity in these tests for DENV and SARS-CoV-2 infections (1,2). DENV antibodies can cross-react with other flaviViruses, including Zika Virus. To assess the potential cross-reactivity of SARS-CoV-2, DENV, and Zika Virus IgM antibodies, serum specimens from 97 patients from Puerto Rico and 12 U.S.-based patients with confirmed COVID-19 were tested using the DENV Detect IgM Capture enzyme-linked immunosorbent assay (ELISA) (InBios International).* In addition, 122 serum specimens from patients with confirmed dengue and 121 from patients with confirmed Zika Virus disease (all from Puerto Rico) were tested using the SARS-CoV-2 pan-Ig Spike Protein ELISA (CDC).| Results obtained for DENV, Zika Virus IgM, and SARS-CoV-2 antibodies indicated 98% test specificity and minimal levels of cross-reactivity between the two flaviViruses and SARS-CoV-2. These findings indicate that diagnoses of dengue or Zika Virus Diseases with the serological assays described in this report are not affected by COVID-19, nor do dengue or Zika Virus Diseases interfere with the Diagnosis of COVID-19.
• Subjects:
  Antibodies, Viral COVID-19 Cross Reactions Dengue Dengue Virus Enzyme-Linked Immunosorbent Assay Humans Immunoglobulin M SARS-CoV-2 Sensitivity And Specificity Serologic Tests Zika Virus Zika Virus Infection

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 71(10):375-377
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7110a3
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  35271558
• Pubmed Central ID:
  PMC8912001
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  3 pdf pages
• Volume:
  71
• Issue:
  10
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:75aad7cb59b9bd774d5c361d2e2022825c1a609b134daedf5245e0693241131b3d21e2830bf94338f589d95c12653b1f7bb98ef360e07fa006d2d827e7497d8a
• Download URL:
  https://stacks.cdc.gov/view/cdc/115834/cdc_115834_DS1.pdf
• File Type:
  [PDF - 148.83 KB ]